BIZTRAC BETA
Wholesale of pharmaceutical and medical goods

TAKEDA AS

Org. no. 980347257 Limited company (AS) Asker Incorporated 1998 Active
Ownership graph ↗
Revenue 2025 NOK 994.9m
Operating profit NOK 57.8m
Equity NOK 298.0m
Incorporated 1998
Employees 53
Share capital NOK 619,000

TAKEDA AS is registered as a limited company in Asker, Akershus with organisation number 980347257. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 1998 and has 53 registered employees. Registered share capital is NOK 619,000, divided into 296 shares. The company's stated purpose is: “Forskning, utvikling, markedsføring og salg av farmasøytiske produkter og virksomhet som er relatert til dette. Formålet kan fremmes ved deltagelse eller samarbeid med andre foretak i inn- og utland.”. The most recent filed accounts, for the 2025 financial year, show NOK 994.9m in revenue and NOK 57.8m in operating profit.

Key figures · 2025

Revenue
NOK 994.9m
Operating profit
NOK 57.8m
Equity
NOK 298.0m
Est. value
NOK 394.6m

Financial health · 2025

Liquidity
2.93
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
62.0%
Very good
Equity as a share of total capital

Who owns TAKEDA AS?

TAKEDA PHARMA. INT. AG TPIZ
TAKEDA AS
NOK 994.9m rev. · NOK 57.8m profit

TAKEDA AS has 1 registered shareholder:

All shareholders and roles →

Group structure

TAKEDA AS er morselskap for 2 datterselskaper:

Frequently asked questions about TAKEDA AS

Who owns TAKEDA AS?

TAKEDA PHARMA. INT. AG TPIZ is the largest registered owner, with 100.0%.

What is the revenue of TAKEDA AS?

TAKEDA AS had revenue of NOK 994.9m in 2025.

Who is the general manager of TAKEDA AS?

Koki Sato is registered as general manager of TAKEDA AS.

Where is TAKEDA AS based?

TAKEDA AS has its business address in Asker.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.